Xfin Spray Spray

About Xfin Spray 1 gm/100 gm

Xfin Spray is a terbinafine hydrochloride spray from Square Pharmaceuticals PLC. It comes as a 1 gm/100 gm spray and belongs to the allylamine group of antifungal medicines used for certain fungal skin infections.

There are 4 brands of Terbinafine Hydrochloride listed in Bangladesh. The lowest listed price is Anpar 1% Cream at ৳ 35.00 per unit.

What is Xfin Spray 1 gm/100 gm?

Xfin Spray is an antifungal medicine made by Square Pharmaceuticals PLC. Its active ingredient is terbinafine hydrochloride, given as a 1 gm/100 gm spray. Terbinafine is an allylamine antifungal that works by interfering with a step in the making of ergosterol, a substance the fungal cell membrane needs. This can lead to fungal cell death. The spray form is applied to the skin. It is used for fungal skin infections caused by certain dermatophytes and yeasts, such as Trichophyton, Microsporum canis and Epidermophyton floccosum. Ask your doctor whether it suits your infection.

Uses of Xfin Spray

Xfin Spray is used for fungal infections of the skin caused by organisms such as Trichophyton species, Microsporum canis and Epidermophyton floccosum, as well as certain yeasts. It is an antifungal preparation of the allylamine type. It is not meant for every skin problem, and other forms of terbinafine are used for nail or scalp infections. A doctor or pharmacist can confirm whether your condition is a fungal infection that this spray is suitable for.

How to use Xfin Spray

Xfin Spray is applied to the affected skin. The doctor decides how often to use it and for how long, since the dose and course depend on your condition. Follow the doctor's instructions and read the product leaflet for application guidance. Do not use it on areas or for problems the doctor has not checked. If your skin gets worse or does not improve, contact your doctor or pharmacist rather than changing the use yourself.

Side effects of Xfin Spray

Skin reactions can occur with terbinafine products, including rash, itching and hives. Some people have reported other effects such as stomach symptoms, changes in liver tests, taste disturbance, and in rare cases serious skin reactions and allergic reactions. Many side effects are mild and short-lived. If you notice swelling, a severe rash, or any worrying reaction, stop using the spray and seek medical advice promptly.

Safety and precautions

Tell your doctor if you are allergic to terbinafine or any ingredient of the spray. Use in pregnancy and breastfeeding should be discussed with a doctor before starting; the safety of this form in pregnancy is not well established from clinical experience. People with liver problems or ongoing skin conditions should ask a doctor first. Keep it away from the eyes and out of children's reach. Store in a cool, dry place below 30°C, protected from light.

Frequently asked questions

What does the generic name terbinafine hydrochloride mean?

Terbinafine hydrochloride is the active substance in Xfin Spray. It is an allylamine antifungal that interferes with ergosterol production in fungal cells, which can lead to fungal cell death. The hydrochloride form is the salt used in the medicine.

What is Xfin Spray used for and what kind of medicine is it?

It is an antifungal spray for fungal skin infections caused by certain dermatophytes and yeasts. It belongs to the allylamine group. A doctor or pharmacist can confirm whether your skin problem is the type this spray is meant to treat.

How should Xfin Spray be taken?

It is applied to the affected skin. The doctor decides the dose, how often to apply it and how long to continue, based on your condition. Follow their instructions and the product leaflet. Ask your doctor or pharmacist if you are unsure how to use it.

Who should ask a doctor before using Xfin Spray?

Anyone allergic to terbinafine, pregnant or breastfeeding women, people with liver problems, and those with an uncertain skin diagnosis should speak to a doctor first. A pharmacist can also advise on correct use and storage.

Indications

Terbinafine tablet: This tablet is indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium).

Terbinafine granules: This is indicated in Tinea Capitis.

Terbinafine cream: Fungal ... Read moreTerbinafine tablet: This tablet is indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium).

Terbinafine granules: This is indicated in Tinea Capitis.

Terbinafine cream: Fungal infection of the skin caused by Trichophyton (e.g. T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidermophyton floccosum. Yeast infections of the skin, principally those caused by the genus Candida (e.g. C. albicans). Pityriasis (tinea) versicolor due to Pityrosporum orbicular (also known as Malassezia furfur).

Terbinafine 1% Spray: This spray is indicated in the treatment of tinea infections of the skin. This spray is also indicated in the treatment of pityriasis (tinea) versicolor due to Malassezia furfur.

Pharmacology

Terbinafine, an Allylamine antifungal, inhibits biosynthesis of Ergosterol (an essential component of fungai cell membrane) via inhibition of Squalene Epoxidase enzyme. This results in fungal cell death primarily due to the increased membrane permeability mediated by the accumulation of high concentrations of Squalene but not due to Ergosterol deficiency. Depending on the concentration of the drug and the fungal species test in vitro, Terbinafine hydrochloride may be fungicidal. However, the clinical significance of in vitro data is unknown. Terbinafine has been shown to be active against most strains of the following microorganisms both in vitro and in clinical infections: Tricophyton Mentagrophyte, Trichophyton Rubrum.

Dosage & Administration

Terbinafine tablet:
  • For the treatment of fingernail onychomycosis: Terbinafine 250 mg (one tablet), once daily for 6 weeks.
  • For the treatment of toenail onychomycosis: Terbinafine 250 mg (one tablet), once daily for 12 weeks.
  • The optimal clinical effect is seen some months after mycological cure and cessation of treatment. This is related to the period required for the outgrowth of healthy nail.
Terbinafine granules:
  • Body Weight: <25 kg: 125 mg/day up to 6 weeks
  • Body Weight: 25-35 kg: 187.5 mg/day up to 6 weeks
  • Body Weight: >35 kg: 250 mg/day up to 6 weeks
Terbinafine cream: Terbinafine cream can be applied once or twice daily. Cleanse and dry the affected areas thoroughly before application of the terbinafine cream. Apply the cream to the affected skin and the surrounding area in a thin layer and rub in lightly. In the case of intertriginous infections (submammary, interdigital, intergluteal, inguinal) the application may be covered with a gauze strip, especially at night. The likely durations of treatment are as follows:
  • Tinea corporis, cruris: 1 to 2 weeks
  • Tinea pedis: 1 week
  • Cutaneous candidiasis: 2 weeks
  • Pityriasis versicolor: 2 weeks
Relief of the clinical symptoms usually occurs within a few days. Irregular use or premature discontinuation of treatment carries the risk of recurrence. If there are no signs of improvement after two weeks, the diagnosis should be verified.

Terbinafine 1% Spray: This spray is applied once or twice daily, depending on the indication. The affected areas should be cleansed and dried thoroughly before application of this spray. A sufficient amount of solution should be applied to wet the treatment area(s) thoroughly.
  • Tinea pedis: once a day,1 week
  • Tinea corporis/cruris: once a day,1 week
  • Pityriasis versicolor: twice a day, 1 week
Relief of clinical symptoms usually occurs within a few days. If there are no signs of improvement after two weeks the diagnosis should be verified.

Interaction

In vivo studies have shown that terbinafine is an inhibitor of the CYP450 2D6 isozyme. Drugs predominantly metabolized by the CYP450 2D6 isozyme include the following drug classes: tricyclic antidepressants, selective serotonin reuptake inhibitors, beta-blockers, antiarrhythmics class 1C (e.g., flecainide and propafenone) and monoamine oxidase inhibitors Type B. Co-administration of terbinafine should be done with careful monitoring and may require a reduction in dose of the 2D6-metabolized drug.

Contraindications

Terbinafine tablet and cream are contra-indicated in individuals with hypersensitive to terbinafine.

Side Effects

The adverse events reported encompass gastrointestinal symptoms (including diarrhea, dyspepsia and abdominal pain), liver test abnormalities, rashes, urticaria, pruritus, and taste disturbances. In general, the adverse events were mild, transient, and did not lead to discontinuation. Adverse events, based on worldwide experience with terbinafine use, include: idiosyncratic and symptomatic hepatic injury and more rarely, cases of liver failure, some leading to death or liver transplant, serious skin reactions, severe neutropenia, thrombocytopenia, angioedema and allergic reactions (including anaphylaxis). Other adverse reactions that have been reported include malaise, fatigue, vomiting, arthralgia, myalgia, and hair loss.

Pregnancy & Lactation

Terbinafine tablet: There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, and because treatment of onychomycosis can be postponed until after pregnancy is completed, it is recommended that terbinafine not be initiated during pregnancy. After oral administration, terbinafine is present in the breast milk of nursing mothers. Treatment with terbinafine is not recommended in nursing mothers.

Terbinafine cream: Foetal toxicity and fertility studies in animals suggest no adverse effects. There is no clinical experience with terbinafine in pregnant women; therefore, unless the potential benefits outweigh any potential risk, terbinafine should not be administered. Terbinafine is excreted in breast milk and therefore mothers should not receive terbinafine treatment whilst breast-feeding.

Precautions & Warnings

Warnings-
  • Terbinafine tablets: Rare cases of liver failure, some leading to death or liver transplant, have occurred with the use of terbinafine tablets for the treatment of onychomycosis in individuals with and without preexisting liver disease. In the majority of liver cases reported in association with terbinafine use, the patients had serious underlying systemic conditions and an uncertain causal association with terbinafine. The severity of hepatic events and/or their outcome may be worse in patients with active or chronic liver disease. Treatment with terbinafine tablets should be discontinued if there is biochemical or clinical evidence of liver injury. There have been isolated reports of serious skin reaction (e.g., Stevens-Johnson Syndrome and toxic epidermal necrolysis). If progressive skin rash occurs, treatment with terbinafine should be discontinued.
  • Terbinafine cream: Terbinafine cream is for external use only. Contact with the eyes should be avoided.
Precautions: Terbinafine are not recommended for patients with chronic or active liver disease. Before prescribing Terbinafine, pre-existing liver disease should be assessed. Hepatotoxicity may occur in patients with and without pre-existing liver disease. Pretreatment serum transaminase (ALT and AST) teste are advised for all patients before taking terbinafine tablets.

Overdose Effects

Clinical experience regarding overdose with terbinafine tablets is limited. Doses up to 5 gm (20 times the therapeutic daily dose) have been taken without inducing serious adverse reactions. The symptoms of overdose included nausea, vomiting, abdominal pain, dizziness, rash, frequent urination, and headache.

Storage Conditions

Store in a cool and dry place, below 30°C, protect from light.

Alternative brands of Terbinafine Hydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.